Business Wire

Critical Therapeutics Initiates Pharmacokinetic Studies of Zileuton Controlled-Release Tablets; Data to support New Drug Application for twice-a-day formulation of zileuton

"The controlled-release formulation extends our patent protection to 2012 and represents an opportunity to continue to expand our market potential for zileuton by offering a more convenient dosing ...
Business Line

Researchers develop controlled-release oral tablet for kala azar, fungal infections

https://www.thehindubusinessline.com/news/science/researchers-develop-controlled-release-oral-tablet-for-kala-azar-fungal-infections/article29221280.ece Copy ...
Medscape

Efficacy and Tolerability of Oxycodone Hydrochloride Controlled-Release Tablets in Moderate to Severe Cancer Pain

Between April 2005 and December 2005, 216 patients (142 inpatients and 74 outpatients) from ten hospitals were enrolled. There were 126 male and 90 female patients (a ratio of 1.4:1). Of the 216 ...
Medindia

Phase 3 Open-Label Study Comparing Tapentadol Extended Release Tablets to Oxycodone Controlled Release Tablets Published by Pain Practice

The median duration of treatment was substantially longer with tapentadol ER (268 days) than with oxycodone CR (59 days), and the incidence of overall gastrointestinal treatment-emergent adverse ...
Finanznachrichten

Lotus Pharmaceuticals, Inc. Announces Patent Pending Gliclazide-Controlled Release Tablets

BEIJING, July 30 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc. (BULLETIN BOARD: LTUS) ("Lotus" or the "Company") a growing developer and producer of prescriptions drugs and licensed ...
Medscape

Efficacy and Tolerability of Oxycodone Hydrochloride Controlled-Release Tablets in Moderate to Severe Cancer Pain

Background and Objective: Oxycodone is a semisynthetic opioid analgesic drug classed as a strong opioid. The controlled-release oxycodone tablet formulation (OCRT) was approved in China in 2004 for ...